{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:42:59Z","timestamp":1785462179870,"version":"3.56.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-024-06111-5","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T12:02:07Z","timestamp":1728388927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of beliefs and attitudes towards benzodiazepines using machine learning based on social media posts: an observational study"],"prefix":"10.1186","volume":"24","author":[{"given":"Laura","family":"de Anta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Alvarez-Mon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Pereira-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina C.","family":"Donat-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Lara-Abelenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Montero-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cielo","family":"Garc\u00eda-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Fraile-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melchor","family":"Alvarez-Mon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"6111_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M. Benzodiazepine Use in the United States. JAMA Psychiatry. 2015;72:136\u201342.","journal-title":"JAMA Psychiatry"},{"key":"6111_CR2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1177\/0269881107077355","volume":"21","author":"JLR Martin","year":"2007","unstructured":"Martin JLR, Sainz-Pardo M, Furukawa TA, Martin-Sanchez E, Seoane T, Galan C. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J Psychopharmacol. 2007;21:774\u201382.","journal-title":"J Psychopharmacol"},{"key":"6111_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/00005053-199708000-00006","volume":"185","author":"AJLM Van Balkom","year":"1997","unstructured":"Van Balkom AJLM, Barker A, Spinhoven P, Blaauw BMJW, Smeenk S, Ruesink B. A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. J Nerv Ment Dis. 1997;185:510\u20136.","journal-title":"J Nerv Ment Dis"},{"key":"6111_CR4","doi-asserted-by":"publisher","unstructured":"Quagliato LA, Freire RC, Nardi AE. Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines. https:\/\/doi.org\/10.1080\/1474033820181429403. 2018;17:315\u201324.","DOI":"10.1080\/1474033820181429403"},{"key":"6111_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/0269881105059253","volume":"19","author":"DS Baldwin","year":"2005","unstructured":"Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JRT, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2005;19:567\u201396.","journal-title":"J Psychopharmacol"},{"key":"6111_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Nix CA, Hollier J, Sagrera CE, Delacroix BM, Abubakar T, et al. Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int. 2021;13:594\u2013607.","journal-title":"Neurol Int"},{"key":"6111_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.18773\/austprescr.2015.055","volume":"38","author":"J Brett","year":"2015","unstructured":"Brett J, Murnion B. Management of benzodiazepine misuse and dependence. Aust Prescr. 2015;38:152\u20135.","journal-title":"Aust Prescr"},{"key":"6111_CR8","doi-asserted-by":"crossref","unstructured":"Tyrer P. Risks of dependence on benzodiazepine drugs: the importance of patient selection. BMJ. 1989;298.","DOI":"10.1136\/bmj.298.6666.102"},{"key":"6111_CR9","unstructured":"benzo.org.uk. 4.1 Hypnotics and anxiolytics : British National Formulary. https:\/\/benzo.org.uk\/BNF.htm. Accessed 19 Jan 2023."},{"key":"6111_CR10","unstructured":"benzo.org.uk. - The Effects of Tranquillization: Health Canada 1982 : Overview. https:\/\/www.benzo.org.uk\/hcb\/hcb2.htm. Accessed 19 Jan 2023."},{"key":"6111_CR11","unstructured":"Scopus preview - Scopus. - Document details - Current problems in Pharmacovigilance. https:\/\/www.scopus.com\/record\/display.uri?eid=2-s2.0-85075528131&origin=inward&txGid=f23ef6d5478bc210d637ac6923d39799. Accessed 19 Jan 2023."},{"key":"6111_CR12","unstructured":"Plan d\u2019actions de l\u2019ANSM visant \u00e0 r\u00e9duire le m\u00e9susage des. benzodiaz\u00e9pines - Point d\u2019information - ANSM: Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. https:\/\/archiveansm.integra.fr\/S-informer\/Points-d-information-Points-d-information\/Plan-d-actions-de-l-ANSM-visant-a-reduire-le-mesusage-des-benzodiazepines-Point-d-information. Accessed 19 Jan 2023."},{"key":"6111_CR13","first-page":"1","volume":"48","author":"H Ashton","year":"2012","unstructured":"Ashton H. Guidelines for the rational use of benzodiazepines. Drugs 1994. 2012;48:1.","journal-title":"Drugs 1994"},{"key":"6111_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00228-004-0808-2","volume":"60","author":"R Lagnaoui","year":"2004","unstructured":"Lagnaoui R, Depont F, Fourrier A, Abouelfath A, B\u00e9gaud B, Verdoux H, et al. Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol. 2004;60:523\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"6111_CR15","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.3399\/bjgp17X691865","volume":"67","author":"J Davies","year":"2017","unstructured":"Davies J, Rae TC, Montagu L. Long-term benzodiazepine and Z-drugs use in England: a survey of general practice. Br J Gen Pract. 2017;67:e609\u201313.","journal-title":"Br J Gen Pract"},{"key":"6111_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/pds.784","volume":"12","author":"R van Hulten","year":"2003","unstructured":"van Hulten R, Isacson D, Bakker A, Leufkens HG. Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidemiol Drug Saf. 2003;12:49\u201353.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6111_CR17","unstructured":"benzo.org.uk: Benzodiazepines: How They Work & How to Withdraw, Prof CH, Ashton DM. FRCP, 2002. https:\/\/www.benzo.org.uk\/manual\/index.htm. Accessed 1 Dec 2022."},{"key":"6111_CR18","doi-asserted-by":"crossref","unstructured":"Fenton MC, Keyes KM, Martins SS, Hasin DS. The role of a prescription in anxiety medication use, abuse, and dependence. https:\/\/doi.org\/101176\/appi.ajp201009081132. 2010;167:1247\u201353.","DOI":"10.1176\/appi.ajp.2010.09081132"},{"key":"6111_CR19","doi-asserted-by":"crossref","unstructured":"Bonnay M, Soeiro T, Megard R, Micallef J, Rol-Land B, Chappuy M. Cahier de d\u00e9veloppement professionnel continu Usages et bon usage des benzodiaz\u00e9pines anxiolytiques et hypnotiques Uses and proper use of anxiolytic and hypnotic benzodiazepines. 2021.","DOI":"10.1016\/j.amp.2021.08.009"},{"key":"6111_CR20","unstructured":"The TEDS, Report. Admissions Reporting Benzodiazepine and Narcotic Pain Reliever Abuse at Treatment Entry. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/BenzodiazepineAndNarcoticPainRelieverAbuse\/BenzodiazepineAndNarcoticPainRelieverAbuse\/BenzodiazepineAndNarcoticPainRelieverAbuse.htm. Accessed 19 Jan 2023."},{"key":"6111_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/pds.967","volume":"14","author":"DD French","year":"2005","unstructured":"French DD, Campbell R, Spehar A, Angaran DM. Benzodiazepines and injury: a risk adjusted model. Pharmacoepidemiol Drug Saf. 2005;14:17\u201324.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6111_CR22","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(98)04087-2","volume":"352","author":"F Barbone","year":"1998","unstructured":"Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet. 1998;352:1331\u20136.","journal-title":"Lancet"},{"key":"6111_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2165\/11533170-000000000-00000","volume":"24","author":"BE Smink","year":"2010","unstructured":"Smink BE, Egberts ACG, Lusthof KJ, Uges DRA, De Gier JJ. The relationship between benzodiazepine use and traffic accidents: a systematic literature review. CNS Drugs. 2010;24:639\u201353.","journal-title":"CNS Drugs"},{"key":"6111_CR24","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1001\/archinte.164.14.1567","volume":"164","author":"AK Wagner","year":"2004","unstructured":"Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, et al. Benzodiazepine Use and Hip fractures in the Elderly: who is at Greatest Risk? Arch Intern Med. 2004;164:1567\u201372.","journal-title":"Arch Intern Med"},{"key":"6111_CR25","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","volume":"106","author":"MA Bachhuber","year":"2016","unstructured":"Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing Benzodiazepine prescriptions and Overdose Mortality in the United States, 1996\u20132013. Am J Public Health. 2016;106:686\u20138.","journal-title":"Am J Public Health"},{"key":"6111_CR26","unstructured":"Overdose Death Rates | National Institute on Drug Abuse (NIDA). https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates. Accessed 19 Jan 2023."},{"key":"6111_CR27","unstructured":"Multiple Cause of Death. 1999\u20132020. https:\/\/wonder.cdc.gov\/wonder\/help\/mcd.html. Accessed 19 Jan 2023."},{"key":"6111_CR28","unstructured":"FDA Drug Safety Communication. FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning | FDA. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or. Accessed 19 Jan 2023."},{"key":"6111_CR29","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing opioids for Chronic Pain\u2014United States, 2016. JAMA. 2016;315:1624\u201345.","journal-title":"JAMA"},{"key":"6111_CR30","doi-asserted-by":"publisher","unstructured":"Neves IT, Sara J, Oliveira S, Catarina M, Fernandes C, Santos OR et al. Physicians\u2019 beliefs and attitudes about benzodiazepines: a cross-sectional study. https:\/\/doi.org\/10.1186\/s12875-019-0965-0","DOI":"10.1186\/s12875-019-0965-0"},{"key":"6111_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamacardio.2018.1511","volume":"3","author":"MG Nanna","year":"2018","unstructured":"Nanna MG, Navar AM, Zakroysky P, Xiang Q, Goldberg AC, Robinson J, et al. Association of Patient Perceptions of Cardiovascular Risk and beliefs on statin drugs with racial differences in statin use: insights from the patient and Provider Assessment of lipid Management Registry. JAMA Cardiol. 2018;3:739\u201348.","journal-title":"JAMA Cardiol"},{"key":"6111_CR32","doi-asserted-by":"crossref","unstructured":"Bradley CK, Wang TY, Li S, Robinson JG, Roger VL, Goldberg AC et al. Patient-reported reasons for declining or discontinuing statin therapy: insights from the PALM registry. J Am Heart Assoc. 2019;8.","DOI":"10.1161\/JAHA.118.011765"},{"key":"6111_CR33","doi-asserted-by":"crossref","unstructured":"Kanchan S, Gaidhane A. Social Media Role and its impact on Public Health: a narrative review. Cureus. 2023;15.","DOI":"10.7759\/cureus.33737"},{"key":"6111_CR34","doi-asserted-by":"crossref","unstructured":"Kusudo M, Terada M, Kureyama N, Wanifuchi-Endo Y, Fujita T, Asano T et al. Characterizing user demographics in posts related to breast, lung and colon cancer on Japanese twitter (X). Scientific Reports 2024 14:1. 2024;14:1\u20138.","DOI":"10.1038\/s41598-024-56679-x"},{"key":"6111_CR35","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/asi.22713","volume":"63","author":"D Wilkinson","year":"2012","unstructured":"Wilkinson D, Thelwall M. Trending Twitter topics in English: an international comparison. J Am Soc Inform Sci Technol. 2012;63:1631\u201346.","journal-title":"J Am Soc Inform Sci Technol"},{"key":"6111_CR36","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2105\/AJPH.2016.303512","volume":"107","author":"L Sinnenberg","year":"2017","unstructured":"Sinnenberg L, Buttenheim AM, Padrez K, Mancheno C, Ungar L, Merchant RM. Twitter as a Tool for Health Research: a systematic review. Am J Public Health. 2017;107:e1\u20138.","journal-title":"Am J Public Health"},{"key":"6111_CR37","doi-asserted-by":"crossref","unstructured":"de Anta L, Alvarez-Mon MA, Ortega MA, Salazar C, Donat-Vargas C, Santoma-Vilaclara J et al. Areas of Interest and Social Consideration of Antidepressants on English tweets: a Natural Language Processing classification study. J Pers Med. 2022;12.","DOI":"10.3390\/jpm12020155"},{"key":"6111_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12178-020-09600-8","volume":"13","author":"JM Helm","year":"2020","unstructured":"Helm JM, Swiergosz AM, Haeberle HS, Karnuta JM, Schaffer JL, Krebs VE, et al. Machine learning and Artificial Intelligence: definitions, applications, and future directions. Curr Rev Musculoskelet Med. 2020;13:69\u201376.","journal-title":"Curr Rev Musculoskelet Med"},{"key":"6111_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.amsu.2020.12.043","volume":"62","author":"N Al-Azzam","year":"2021","unstructured":"Al-Azzam N, Shatnawi I. Comparing supervised and semi-supervised machine learning models on diagnosing breast Cancer. Annals Med Surg. 2021;62:53.","journal-title":"Annals Med Surg"},{"key":"6111_CR40","first-page":"163","volume":"264","author":"H Hu","year":"2019","unstructured":"Hu H, Phan NH, Geller J, Iezzi S, Vo H, Dou D, et al. An Ensemble Deep Learning Model for drug abuse detection in Sparse Twitter-Sphere. Stud Health Technol Inf. 2019;264:163\u20137.","journal-title":"Stud Health Technol Inf"},{"key":"6111_CR41","doi-asserted-by":"publisher","first-page":"1282026","DOI":"10.3389\/fpsyt.2024.1282026","volume":"15","author":"C Castillo-Toledo","year":"2024","unstructured":"Castillo-Toledo C, Fraile-Mart\u00ednez O, Donat-Vargas C, Lara-Abelenda FJ, Ortega MA, Garcia-Montero C, et al. Insights from the Twittersphere: a cross-sectional study of public perceptions, usage patterns, and geographical differences of tweets discussing cocaine. Front Psychiatry. 2024;15:1282026.","journal-title":"Front Psychiatry"},{"key":"6111_CR42","doi-asserted-by":"crossref","unstructured":"Carabot F, Fraile-Mart\u00ednez O, Donat-Vargas C, Santoma J, Garcia-Montero C, da Costa MP et al. Understanding public perceptions and discussions on Opioids through Twitter: cross-sectional infodemiology study. J Med Internet Res. 2023;25.","DOI":"10.2196\/50013"},{"key":"6111_CR43","first-page":"13","volume":"12","author":"A Mullin","year":"2024","unstructured":"Mullin A, Scott M, Vaccaro G, Floresta G, Arillotta D, Catalani V, et al. Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present using Analytical and Social listening techniques. Pharm (Basel). 2024;12:13.","journal-title":"Pharm (Basel)"},{"key":"6111_CR44","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/eurpub\/ckac161","volume":"32","author":"A Sarker","year":"2022","unstructured":"Sarker A, Al-Garadi MA, Ge Y, Nataraj N, McGlone L, Jones CM, et al. Evidence of the emergence of illicit benzodiazepines from online drug forums. Eur J Public Health. 2022;32:939.","journal-title":"Eur J Public Health"},{"key":"6111_CR45","doi-asserted-by":"crossref","unstructured":"Alvarez-Mon MA, del Barco AA, Lahera G, Quintero J, Ferre F, Pereira-Sanchez V et al. Increasing Interest of Mass Communication Media and the General Public in the distribution of Tweets about Mental disorders: Observational Study. J Med Internet Res. 2018;20.","DOI":"10.2196\/jmir.9582"},{"key":"6111_CR46","doi-asserted-by":"publisher","first-page":"e17626","DOI":"10.2196\/17626","volume":"22","author":"I Viguria","year":"2020","unstructured":"Viguria I, Alvarez-Mon MA, Llavero-Valero M, Asunsolo del Barco A, Ortu\u00f1o F, Alvarez-Mon M. Eating disorder awareness campaigns: thematic and quantitative analysis using Twitter. J Med Internet Res. 2020;22:e17626.","journal-title":"J Med Internet Res"},{"key":"6111_CR47","doi-asserted-by":"crossref","unstructured":"Pereira-Sanchez V, Alvarez-Mon MA, Del Barco AA, Alvarez-Mon M, Teo A. Exploring the extent of the Hikikomori Phenomenon on Twitter: mixed methods study of Western Language tweets. J Med Internet Res. 2019;21.","DOI":"10.2196\/preprints.14167"},{"key":"6111_CR48","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1192\/j.eurpsy.2022.2359","volume":"66","author":"L de Anta","year":"2023","unstructured":"de Anta L, Alvarez-Mon MA, Donat-Vargas C, Lara-Abelanda FJ, Pereira-Sanchez V, Rodriguez CG, et al. Assessment of beliefs and attitudes about electroconvulsive therapy posted on Twitter: an observational study. Eur Psychiatry. 2023;66:e11.","journal-title":"Eur Psychiatry"},{"key":"6111_CR49","doi-asserted-by":"crossref","unstructured":"Conneau A, Khandelwal K, Goyal N, Chaudhary V, Wenzek G, Guzm\u00e1n F et al. Unsupervised Cross-lingual Representation Learn Scale. 2020;:8440\u201351.","DOI":"10.18653\/v1\/2020.acl-main.747"},{"key":"6111_CR50","unstructured":"Fujino A, Isozaki H, Suzuki J. Multi-label text categorization with Model Combination based on F1-score maximization. 2008."},{"key":"6111_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-023-17617-0","volume":"24","author":"F Correia Lopes","year":"2024","unstructured":"Correia Lopes F, Pinto da Costa M, Fernandez-Lazaro CI, Lara-Abelenda FJ, Pereira-Sanchez V, Teo AR, et al. Analysis of the hikikomori phenomenon \u2013 an international infodemiology study of Twitter data in Portuguese. BMC Public Health. 2024;24:1\u201312.","journal-title":"BMC Public Health"},{"key":"6111_CR52","doi-asserted-by":"crossref","unstructured":"Baker W, Colditz JB, Dobbs PD, Mai H, Visweswaran S, Zhan J et al. Classification of Twitter Vaping Discourse using BERTweet: comparative deep learning study. JMIR Med Inf. 2022;10.","DOI":"10.2196\/33678"},{"key":"6111_CR53","doi-asserted-by":"crossref","unstructured":"Alvarez-Mon MA, Donat-Vargas C, Santoma-Vilaclara J, de Anta L, Goena J, Sanchez-Bayona R et al. Assessment of Antipsychotic Medications on Social Media: machine learning study. Front Psychiatry. 2021;12.","DOI":"10.3389\/fpsyt.2021.737684"},{"key":"6111_CR54","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s11606-007-0251-z","volume":"22","author":"N Buscemi","year":"2007","unstructured":"Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007;22:1335\u201350.","journal-title":"J Gen Intern Med"},{"key":"6111_CR55","doi-asserted-by":"publisher","first-page":"e208953","DOI":"10.1001\/jamanetworkopen.2020.8953","volume":"3","author":"S Golder","year":"2020","unstructured":"Golder S, O\u2019Connor K, Hennessy S, Gross R, Gonzalez-Hernandez G. Assessment of beliefs and attitudes about statins posted on Twitter. JAMA Netw Open. 2020;3:e208953.","journal-title":"JAMA Netw Open"},{"key":"6111_CR56","doi-asserted-by":"crossref","unstructured":"Gomez AF, Barthel AL, Hofmann SG. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review. https:\/\/doi.org\/10.1080\/1465656620181472767. 2018;19:883\u201394.","DOI":"10.1080\/14656566.2018.1472767"},{"key":"6111_CR57","doi-asserted-by":"crossref","unstructured":"Billioti S, B\u00e9gaud B, Bazin F, Verdoux H, Dartigues JF, P\u00e9r\u00e8s K et al. Benzodiazepine use and risk of dementia: prospective population based study. BMJ. 2012;345.","DOI":"10.1136\/bmj.e6231"},{"key":"6111_CR58","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2165\/11599460-000000000-00000","volume":"29","author":"AR Huang","year":"2012","unstructured":"Huang AR, Mallet L, Rochefort CM, Eguale T, Buckeridge DL, Tamblyn R. Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging. 2012;29:359\u201376.","journal-title":"Drugs Aging"},{"key":"6111_CR59","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1517\/14740338.3.5.485","volume":"3","author":"S Madhusoodanan","year":"2004","unstructured":"Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf. 2004;3:485\u201393.","journal-title":"Expert Opin Drug Saf"},{"key":"6111_CR60","unstructured":"Berghaus G, Sticht G, Grellner W, Lenz D, Naumann T, Wiesenm\u00fcller S. D 1.1.2b META-ANALYSIS DRUID 6TH FRAMEWORK PROGRAMME PAGE 2 6th Framework Programme Deliverable D 1.1.2b Meta-analysis of empirical studies concerning the effects of medicines and illegal drugs including pharmacokinetics on safe driving Status. Public; 2010."},{"key":"6111_CR61","doi-asserted-by":"crossref","unstructured":"Voshaar RCO, Couv\u00e9e JE, Van Balkom AJLM, Mulder PGH, Zitman FG. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry. 2006;189 SEP.:213\u201320.","DOI":"10.1192\/bjp.189.3.213"},{"key":"6111_CR62","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/archpsyc.1990.01810220015002","volume":"47","author":"K Rickels","year":"1990","unstructured":"Rickels K, Schweizer E, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines. I. effects of abrupt discontinuation. Arch Gen Psychiatry. 1990;47:899\u2013907.","journal-title":"Arch Gen Psychiatry"},{"key":"6111_CR63","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","volume":"77","author":"M Lader","year":"2014","unstructured":"Lader M, Llb O, Sci M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol. 2014;77:295\u2013301.","journal-title":"Br J Clin Pharmacol"},{"key":"6111_CR64","doi-asserted-by":"crossref","unstructured":"Lader M. Benzodiazepines revisited\u2014will we ever learn? Addiction. 2011;106:2086\u2013109.","DOI":"10.1111\/j.1360-0443.2011.03563.x"},{"key":"6111_CR65","doi-asserted-by":"crossref","unstructured":"Darker CD, Sweeney BP, Barry JM, Farrell MF, Donnelly-Swift E. Psychosocial interventions for benzodiazepine harmful use, abuse or dependence. Cochrane Database Syst Reviews. 2015;2015.","DOI":"10.1002\/14651858.CD009652.pub2"},{"key":"6111_CR66","doi-asserted-by":"crossref","unstructured":"Weich S, Pearce HL, Croft P, Singh S, Crome I, Bashford J et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ. 2014;348.","DOI":"10.1136\/bmj.g1996"},{"key":"6111_CR67","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","volume":"17","author":"J Brandt","year":"2017","unstructured":"Brandt J, Leong C, Benzodiazepines. An updated review of major adverse outcomes reported on in Epidemiologic Research. Drugs R D. 2017;17:493.","journal-title":"Drugs R D"},{"key":"6111_CR68","doi-asserted-by":"publisher","first-page":"103770","DOI":"10.1016\/j.compbiomed.2020.103770","volume":"122","author":"O Edo-Osagie","year":"2020","unstructured":"Edo-Osagie O, De La Iglesia B, Lake I, Edeghere O. A scoping review of the use of Twitter for public health research. Comput Biol Med. 2020;122:103770.","journal-title":"Comput Biol Med"},{"key":"6111_CR69","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1360-0443.1987.tb01529.x","volume":"82","author":"ASHTON H","year":"1987","unstructured":"ASHTON H. Benzodiazepine Withdrawal: outcome in 50 patients. Br J Addict. 1987;82:665\u201371.","journal-title":"Br J Addict"},{"key":"6111_CR70","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.lpm.2018.10.006","volume":"47","author":"F Vorspan","year":"2018","unstructured":"Vorspan F, Barr\u00e9 T, Pariente A, Montastruc F, Tournier M. Faut-Il limiter la dur\u00e9e des traitements par benzodiaz\u00e9pines ? Presse Med. 2018;47:892\u20138.","journal-title":"Presse Med"},{"key":"6111_CR71","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/1047-2797(94)00112-7","volume":"5","author":"CI Neutel","year":"1995","unstructured":"Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine\u2606. Ann Epidemiol. 1995;5:239\u201344.","journal-title":"Ann Epidemiol"},{"key":"6111_CR72","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.4088\/JCP.18m12174","volume":"79","author":"C Blanco","year":"2018","unstructured":"Blanco C, Han B, Jones CM, Johnson K, Compton WM. Prevalence and correlates of Benzodiazepine Use, Misuse, and Use disorders among adults in the United States. J Clin Psychiatry. 2018;79:1865.","journal-title":"J Clin Psychiatry"},{"key":"6111_CR73","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.15585\/mmwr.mm7034a2","volume":"70","author":"S Liu","year":"2021","unstructured":"Liu S, O\u2019Donnell J, Gladden RM, McGlone L, Chowdhury F. Trends in Nonfatal and Fatal overdoses Involving benzodiazepines \u2014 38 States and the District of Columbia, 2019\u20132020. MMWR Morb Mortal Wkly Rep. 2021;70:1136\u201341.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6111_CR74","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.drugpo.2015.08.005","volume":"28","author":"MA Bachhuber","year":"2016","unstructured":"Bachhuber MA, Maughan BC, Mitra N, Feingold J, Starrels JL. Prescription monitoring programs and emergency department visits involving benzodiazepine misuse: early evidence from 11 United States metropolitan areas. Int J Drug Policy. 2016;28:120\u20133.","journal-title":"Int J Drug Policy"},{"key":"6111_CR75","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMp1715050","volume":"378","author":"A Lembke","year":"2018","unstructured":"Lembke A, Papac J, Humphreys K. Our other prescription drug Problem. N Engl J Med. 2018;378:693\u20135.","journal-title":"N Engl J Med"},{"key":"6111_CR76","unstructured":"Scopus preview - Scopus. - Document details - Patterns and correlates of benzodiazepine use in the French general population. https:\/\/www.scopus.com\/record\/display.uri?eid=2-s2.0-5344261760&origin=inward&txGid=e0ae5db19ebc479a6848e7063e2b1434. Accessed 18 Jan 2023."},{"key":"6111_CR77","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.healthpol.2010.03.008","volume":"97","author":"CM Cunningham","year":"2010","unstructured":"Cunningham CM, Hanley GE, Morgan S. Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use. Health Policy (New York). 2010;97:122\u20139.","journal-title":"Health Policy (New York)"},{"key":"6111_CR78","unstructured":"Scopus preview - Scopus. - Document details - Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. https:\/\/www.scopus.com\/record\/display.uri?eid=2-s2.0-12244305528&origin=inward&txGid=121849639123737363ca503274d36d51. Accessed 18 Jan 2023."},{"key":"6111_CR79","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2710.2009.01079.x","volume":"35","author":"JL Westbury","year":"2010","unstructured":"Westbury JL, Jackson S, Peterson GM. Psycholeptic use in aged care homes in Tasmania, Australia. J Clin Pharm Ther. 2010;35:189\u201393.","journal-title":"J Clin Pharm Ther"},{"key":"6111_CR80","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1753-6405.2007.00091.x","volume":"31","author":"A Windle","year":"2007","unstructured":"Windle A, Elliot E, Duszynski K, Moore V. Benzodiazepine prescribing in elderly Australian general practice patients. Aust N Z J Public Health. 2007;31:379\u201381.","journal-title":"Aust N Z J Public Health"},{"key":"6111_CR81","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00228-017-2257-8","volume":"73","author":"E Reeve","year":"2017","unstructured":"Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol. 2017;73:927\u201335.","journal-title":"Eur J Clin Pharmacol"},{"key":"6111_CR82","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","volume":"30","author":"E Reeve","year":"2013","unstructured":"Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30:793\u2013807.","journal-title":"Drugs Aging"},{"key":"6111_CR83","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","volume":"174","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER Cluster randomized trial. JAMA Intern Med. 2014;174:890\u20138.","journal-title":"JAMA Intern Med"},{"key":"6111_CR84","unstructured":"[Benzodiazepine use. in a sample of patients on a treatment program with opiate derivatives (PTDO)] - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/19578731\/. Accessed 18 Jan 2023."},{"key":"6111_CR85","first-page":"43","volume":"22","author":"D EJ","year":"2010","unstructured":"EJ D, MH T, SR W, AA N, BN G. Health-related quality of life in depression: a STAR*D report. Ann Clin Psychiatry. 2010;22:43\u201355.","journal-title":"Ann Clin Psychiatry"},{"key":"6111_CR86","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/BF02939579","volume":"168","author":"S Rooney","year":"1999","unstructured":"Rooney S, Kelly G, Bamford L, Sloan D, O\u2019connor JJ. Co-abuse of opiates and benzodiazepines. Ir J Med Sci. 1999;168:36\u201341.","journal-title":"Ir J Med Sci"},{"key":"6111_CR87","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1046\/j.1360-0443.2000.951217858.x","volume":"95","author":"J Ross","year":"2000","unstructured":"Ross J, Darke S. The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction. 2000;95:1785\u201393.","journal-title":"Addiction"},{"key":"6111_CR88","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/bmj.j760","volume":"356","author":"EC Sun","year":"2017","unstructured":"Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017;356:760.","journal-title":"BMJ"},{"key":"6111_CR89","doi-asserted-by":"publisher","first-page":"103169","DOI":"10.1016\/j.drugpo.2021.103169","volume":"93","author":"MK Laing","year":"2021","unstructured":"Laing MK, Ti L, Marmel A, Tobias S, Shapiro AM, Laing R, et al. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: preliminary results from a community drug checking program using point-of-care and confirmatory methods. Int J Drug Policy. 2021;93:103169.","journal-title":"Int J Drug Policy"},{"key":"6111_CR90","unstructured":"Benzodiazepines and Opioids | National Institute on Drug Abuse (NIDA). https:\/\/nida.nih.gov\/research-topics\/opioids\/benzodiazepines-opioids. Accessed 22 Dec 2022."},{"key":"6111_CR91","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.pain.2010.08.002","volume":"151","author":"BJ Morasco","year":"2010","unstructured":"Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain. 2010;151:625\u201332.","journal-title":"Pain"},{"key":"6111_CR92","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jpain.2011.11.004","volume":"13","author":"KW Saunders","year":"2012","unstructured":"Saunders KW, Von Korff M, Campbell CI, Banta-Green CJ, Sullivan MD, Merrill JO, et al. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012;13:266\u201375.","journal-title":"J Pain"},{"key":"6111_CR93","unstructured":"Utilizaci\u00f3n de medicamentos. ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a | Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/observatorio-de-uso-de-medicamentos\/informes-ansioliticos-hipnoticos\/. Accessed 18 Jan 2023."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06111-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-06111-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06111-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T18:05:44Z","timestamp":1728410744000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-06111-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6111"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-06111-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of Universidad de Alcal\u00e1 and is compliant with the ethical principles from the World Medical Association Declaration of Helsinki (7th revision, 2013). The data used was of public domain and in any case we have ensured confidentiality of the users.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"659"}}